Impact of MS disease-modifying therapies on antibody and T cell responses following COVID-19 vaccination

被引：0
|
作者：
Sabatino, J. [1 ]
Rowles, W. [1 ]
Mittl, K. [1 ]
Mcpolin, K. [1 ]
Rajan, J. [2 ]
Zamecnik, C. [1 ]
Zhao, C. [1 ]
Dandekar, R. [1 ]
Alvarenga, B. [1 ]
Loudermilk, R. [1 ]
Gerungan, C. [1 ]
Spencer, C. [1 ]
Sagan, S. [1 ]
Augusto, D. [1 ]
Alexander, J. [1 ]
Ho, B. [1 ]
Hollenbach, J. [1 ]
Hollenbach, J. [1 ]
Zamvil, S. [1 ]
Bove, R. [1 ]
机构：
[1] Univ Calif San Francisco, Neurol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Med, San Francisco, CA 94143 USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 2_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P979
引用
收藏
页码：795 / 795
页数：1
相关论文
共 50 条
  • [1] COVID-19 and MS disease-modifying therapies
    Berger, Joseph R.
    Brandstadter, Rachel
    Bar-Or, Amit
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2020, 7 (04):
  • [2] The COVID-19 pandemic and the use of MS disease-modifying therapies
    Giovannoni, Gavin
    Hawkes, Chris
    Lechner-Scott, Jeannette
    Levy, Michael
    Waubant, Emmanuelle
    Gold, Julian
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 39
  • [3] How important are COVID-19 vaccine responses in patients with MS on disease-modifying therapies?
    Giovannoni, Gavin
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 63
  • [4] T cell responses to COVID-19 infection and vaccination in patients with multiple sclerosis receiving disease-modifying therapy
    Reder, Anthony T.
    Stuve, Olaf
    Tankou, Stephanie K.
    Leist, Thomas P.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (06) : 648 - 656
  • [5] Antibody and T cell responses to COVID-19 vaccination in patients receiving anticancer therapies
    Rouhani, Sherin Juliet
    Yu, Jovian
    Olson, Daniel
    Zha, Yuanyuan
    Pezeshk, Apameh
    Cabanov, Alexandra
    Pyzer, Athalia R.
    Trujillo, Jonathan
    Derman, Benjamin A.
    O'Donnell, Peter
    Jakubowiak, Andrzej
    Kindler, Hedy L.
    Bestvina, Christine
    Gajewski, Thomas F.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (06)
  • [6] Response of COVID-19 vaccination in multiple sclerosis patients following disease-modifying therapies: A meta-analysis
    Wu, Xi
    Wang, Lu
    Shen, Lu
    Tang, Kefu
    EBIOMEDICINE, 2022, 81
  • [7] Risk of COVID-19 infection and severe disease in MS patients on different disease-modifying therapies
    Smith, Tyler E.
    Madhavan, Maya
    Gratch, Daniel
    Patel, Aneek
    Saha, Valerie
    Sammarco, Carrie
    Rimler, Zoe
    Zuniga, Guadalupe
    Gragui, Dunia
    Charvet, Leigh
    Cutter, Gary
    Krupp, Lauren
    Kister, Ilya
    Ryerson, Lana Zhovtis
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 60
  • [8] Effects of Multiple Sclerosis Disease-Modifying Therapies on Immunological Responses to COVID-19 Vaccination in Hispanic Puerto Rican Patients
    Vega-Corteguera, R.
    Carmona-Burgos, D.
    Martinez-Maldonado, V.
    Gilman, C.
    Diaz-de la Matta, P.
    Vicente-Loperena, I.
    Chinea-Martinez, A.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 79 - 80
  • [9] COVID-19 vaccines and multiple sclerosis disease-modifying therapies
    Giovannoni, Gavin
    Hawkes, Christopher H.
    Lechner-Scott, Jeannette
    Levy, Michael
    Yeh, E. Ann
    Baker, David
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 53
  • [10] Multiple Sclerosis Disease-Modifying Therapies in the COVID-19 Era
    Ciotti, John R.
    Grebenciucova, Elena
    Moss, Brandon P.
    Newsome, Scott D.
    ANNALS OF NEUROLOGY, 2020, 88 (06) : 1062 - 1064
12345